The Problem
The toll of cardiovascular disease in numbers.
Disability-adjusted life years (DALYs)
17,256,624 (USA)
According to the World Health Organization (WHO), cardiovascular disease (CVD) is a major contributor to the global burden of disease, as measured by disability-adjusted life years (DALYs). In 2020, CVD was responsible for over 40.8 million DALYs worldwide. DALYs take into account both the number of years of life lost due to premature death (YLLs) and the number of years of life lost due to disability (YLDs).
In the United States alone, CVD accounted for approximately 17.2 million DALYs. The good news is that CVD is both preventable and treatable. By addressing risk factors, promoting early detection and effective management of CVD, and increasing access to appropriate treatment, many CVD-related deaths could be prevented.
Years of life lost (YLLs)
14,777,616 (USA)
According to the World Health Organization (WHO), cardiovascular disease (CVD) is the primary cause of years of life lost (YLLs) globally due to premature death. In 2020, CVD was responsible for more than 36.4 million YLLs worldwide. YLLs are determined by calculating the difference between the age at death of a person and the age at which they would have passed away if they had not died prematurely. Premature deaths from CVD are considered to occur before the age of 70, as these deaths can often be prevented and treated through appropriate measures.
In the United States, CVD was responsible for approximately 14.8 million YLLs. Addressing risk factors, early detection, effective management, and providing access to treatment are crucial steps in reducing the number of premature deaths caused by CVD.
Years lived with disability (YLDs)
2,479,008 (USA)
The World Health Organization (WHO) recognizes cardiovascular disease (CVD) as a significant contributor to years lived with disability (YLDs) worldwide. In 2020, CVD was responsible for more than 4.5 million YLDs globally. Years lived with disability (YLDs) is a metric used to calculate the number of years a person lives with a disability due to a specific health condition. It is one aspect of the disability-adjusted life years (DALY) measurement, which also considers the years of life lost due to premature death.
In the United States, CVD accounted for approximately 2.5 million YLDs. Effective management and treatment of CVD can help to reduce the number of years a person lives with a disability due to the condition, improving their overall quality of life. Addressing risk factors can the burden of YLDs caused by the disease.
Deaths From Cardiovascular Disease
891,744 (USA)
Tracking deaths caused by cardiovascular disease (CVD) is crucial for monitoring advancements in preventing and treating the condition and for allocating resources and interventions effectively. In the United States, CVD is a leading cause of death, responsible for a staggering 1 in 3 deaths in the country. According to the World Health Organization (WHO), CVD is also one of the leading causes of deaths globally. In 2020, CVD was responsible for over 17.9 million deaths worldwide, representing 31% of all deaths worldwide.
In the United States specifically, CVD was responsible for approximately 891 thousand deaths in 2020. Addressing risk factors and promoting early detection are important steps in reducing the number of deaths caused by the disease.
The tragedy is that these statistics are often avoidable with diagnosis and treatment.
The Opportunity
Only 56% of those with CVD are aware they have it
Cardiovascular Disease
Cardiovascular disease (CVD) refers to a group of conditions that affect the heart and blood vessels, including coronary artery disease, heart failure, and stroke. It is a leading cause of death and disability worldwide, and early detection and treatment can significantly improve outcomes.
Number of CVD Deaths
According to the World Health Organization (WHO), CVD is responsible for 17.9 million deaths per year, which is about 32% of all global deaths. It is estimated that about half of these deaths could be prevented through lifestyle changes, such as maintaining a healthy diet, getting regular physical activity, and avoiding tobacco use.
44% are Undiagnosed & Untreated
However, not all people with CVD are diagnosed or treated. In fact, some studies have found that a significant proportion of people with CVD are undiagnosed and unaware of their condition. For example, a study published in the Journal of the American College of Cardiology in 2016 found that 44% of people with CVD in the United States were unaware that they had the condition. This is concerning because undiagnosed CVD can lead to serious complications, including heart attack and stroke.
Who are the Undiagnosed?
There are several reasons why people with CVD may be undiagnosed. Some may not have any symptoms, or their symptoms may be mild and go unrecognized. Others may not have access to healthcare or may not prioritize their health.
The Importance of Treatment
It is important for people to be aware of the risk factors for CVD, such as high blood pressure, high cholesterol, diabetes, and obesity, and to take steps to reduce their risk through lifestyle changes and, if necessary, medication. Regular check-ups with a healthcare provider can also help identify CVD early and allow for timely treatment.
Targeting the Undiagnosed
We possess the capability to target the 44% of individuals who are currently undiagnosed and untreated, specifically those at the highest risk of cardiovascular events, using the 10- and 30-year Framingham risk prediction models.
How Big is the Opportunity?
In the US, there are 40,524,000 individuals who are undiagnosed and untreated, and 33,816 cardiovascular physicians. This averages to 1,178 new patients per physician, suggesting that it may be feasible to increase the number of patients seen by a physician in most markets.
Out of 92.0M living with CVD in USA, 40.5M are undiagnosed and untreated.
The Solution
The question is, how much do you want to grow?
A 40.5M Target Market
A cardiovascular practice can achieve significant growth by focusing on identifying and treating patients with undiagnosed cardiovascular disease (CVD).
Decision-Making Process
Understanding the decision-making process that prospective patients go through in making decisions about seeking healthcare from cardiologists.
Barriers to Access
Healthcare studies have attempted to explain why a significant proportion of people with cardiovascular disease (CVD) are undiagnosed and untreated.
Heart Risk Targeting
Targeting patients by their heart risk score is a strategy we use to identify and prioritize those who are at a higher risk for developing heart disease.
Patient Lifetime Value
According to a study published in the Journal of the American Heart Association, patients with a higher cardiovascular risk score had higher patient lifetime values.
Financial Performance
By identifying patients at the highest risk of developing cardiovascular diseases, practices can prioritize their care, leading to enhanced financial performance.
Improved Outcomes
By focusing on patients with the highest risk, healthcare providers can dedicate more time and resources to those who need it the most.
Reduced Healthcare Costs
By utilizing risk assessment tools, medical practices can enable early interventions and reduce healthcare expenditures for heart diseases.